Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-03

Clinical Trial Update: Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sufentanil, fentanyl, and remifentanil in combination with midazolam for conscious sedation during bronchoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENTANYL (FENTANYL)
  • Midazolam (Midazolam)
  • Remifentanil (remifentanil)
  • Sufentanil (sufentanil)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Sufentanil, Remifentanil | Phase 4 | Status: COMPLETED